1.1 Editorial Independence
We are dedicated to upholding editorial independence, which means that decisions about submitted manuscript about acceptance, rejection, or revision are based solely on academic merit. This editorial autonomy is essential for preserving the integrity of the peer review process and the editorial decision making process.
1.2 Fair and Unbiased Evaluation
All submissions are subjected to a fair, unbiased, and rigorous evaluation process. Our editors focus on the scientific quality, originality, and significance of each manuscript, regardless of authors' affiliations, backgrounds, or other non-scientific factors.
2.1 Rigorous Peer Review
We follow to a rigorous peer review process, employing experts in the respective fields of health science to evaluate the submitted manuscript. This process ensures that published articles meet high scientific standards and provide valuable insights to the scholarly community.
2.2 Double-Blind Peer Review Policy
The Nobel Journal of Health Sciences (NJHS) adheres to the double-blind peer review process, ensuring that both the author(s) and reviewers remain unware of each other’s identity, thereby preserving the confidentiality of the peer review process.
2.3 Timely Review Process
We are committed to providing authors with timely and constructive feedback, minimizing the time between submission and final editorial decisions. This commitment aligns with our goal of supporting researchers in the prompt dissemination of their findings.
3.1 Research Integrity
We follow established ethical guidelines and encourage the responsible conduct of research, including proper citation of sources, avoidance of plagiarism, and accurate reporting of methodologies and results. We also expected same from the author(s) to uphold the highest standards of research integrity.
3.2 Authorship and Contributor ship
We follow the ICMJE guidelines on authorship and it should be based on substantial contributions to the conception, design, execution, or interpretation of the research. For group authorship, we request author statement file outlining their individual intellectual contribution of the work to emphasize the importance of transparent authorships. We seriously regret the practice of 3G (ghost authorship, gifted authorship and guest authorship). Any published article(s) in NJHS if found these practices will be immediately suspended and authors are blacklisted. The author(s) are of three types; first author, corresponding author and coauthor(s).
3.3 Conflict of Interest
We are committed to transparency regarding potential conflicts of interest. Authors must disclose any financial or personal relationships with other people or organizations that may inappropriately influence or biasness of their research findings. For example, employment, consultancies, paid expert testimony, patent applications or registrations, grants or other findings. Editors and reviewers are also expected to declare any conflicts of interest that may compromise impartial decision-making.
3.4 Plagiarism
Authors are responsible for ensuring that their work is free from plagiarism, and any instances of misconduct are treated with the utmost seriousness. If plagiarism is detected after acceptance or after publication of the paper, the author will be offered a chance for rebuttal. If the author’s rebuttal is not found to be satisfactory, the manuscript will be retracted and the author (s) will be blacklisted.
4.1 Manuscript Preparation
The guidelines for manuscript preparation of manuscript are available in the Author Guidelines. These guidelines address formatting, referencing, and other essential elements to ensure a standardized and streamlined publication process.
4.2 Ethical Approval and Informed Consent
We kindly request that all the author(s) provide ethical approval from the Institutional Review Board and informed consent forms from participants at the time of manuscript submission. This commitment to ethical research practices highlight the Nobel Journal of Health Sciences (NJHS)'s dedication to the welfare of research participants.
5.1 Data Sharing and Reproducibility
We encourage all the authors to share their research data, code, and other relevant materials to promote transparency and reproducibility.
6.1 Editorial Board Evaluation
The Editorial board of the Nobel Journal of Health Sciences (NJHS) regularly reviews and refines its editorial policies to align with evolving standards and best practices in scholarly publishing. We actively seek feedback from authors, reviewers, and readers to guide our continuous improvement efforts.
6.2 Collaborative Initiatives
Nobel Journal of Health Sciences (NJHS) welcome other journals, institutions, and organizations to foster innovation and uphold the highest standards in scholarly publishing.
6.3 Editorial Board Member Removal Policy
The primary purpose of this policy is to give transparent and fair outline for potential removal of an editorial board member. It addresses various grounds for removal, including ethical misconduct, non-performance, professional misconduct, and involvement with predatory journals and publishers.
Ethical Misconduct
Plagiarism: Involvement in plagiarism is sufficient ground for immediate removal from the Editorial Board, as it undermines the integrity of both the journal and the academic community.
Conflict of Interest: Failure to disclose and manage conflicts of interest is also sufficient for discontinuation from editorial board.
Breach of Confidentiality: Unauthorized disclosure of confidential information may result in removal from editorial board.
Non-Performance
Failure to Fulfill Responsibilities: Persistent failure to contribute to the manuscript review process and editorial decision-making are also sufficient for dismissal from the editorial board.
Professional Misconduct
Unprofessional Behavior (S), misuse of position and involvement in Predatory Journal(S), and publisher (s) may result in removal from editorial board.
Removal and replacement Procedures
Any concerned party with evidential proof can file a formal complaint against any Editorial Board member with the Editor-in-Chief. The initial investigation will be conducted by the Editor-in-chief to scrutinize the complaints. If the complaint is deemed genuine, an impartial investigation committee (3- 5 members) will be appointed to conduct a thorough investigation, ensuring objectivity and fairness. It is the duty of the committee members to collect and reviews all the evidence for a comprehensive decision-making process. Based on the committee’s recommendation, the Editor-in-chief will make final decision regarding any needy disciplinary action, corrective measures, or removal that depends upon severity of the violation. The final decision will be promptly notified to the accused member for transparency, accountability and trust in editorial process.
In the event of removal, an interim appointment may be made to ensure continuity in the editorial process, considering expertise, diversity, and alignment with journal goals. The permanent replacement will follow a rigorous nomination and selection process is based on expertise in subject matter, academic credentials, publication records, reviewing experiences, and final interview to maintain high standards.
All manuscripts submitted to NJHS are subjected to a rigorous peer-review process. After passing initial checks, the manuscript will be reviewed by three independent experts. The review process follows a double-blind model, where reviewers and author(s) are not aware of each other’s identities. The comments from the peer-review are confidential and disclosed only with the explicit consent of the reviewer.
An electronic invitation will be sent to the relevant subject experts including the title, abstract, and keywords of the manuscript for review. Upon acceptance, a 28 days’ timeframe is assigned to the reviewers to complete the review process. After this period, reviews become overdue. In the case of non-response, the manuscript invitation is withdrawn, and an alternative reviewer is approached.
The corresponding author will receive an email once the reviewers submit their comments to the Nobel Journal of Health Sciences (NJHS). The Editor checks the comments and forwards them to the corresponding author, with or without additional remarks. The corresponding author must resubmit the revised manuscript, addressing both editorial and reviewer comments, within two weeks. Failure to submit the revised version within the stipulated timeframe results in the article being considered rejected, and its metadata will be removed from the system.
The revised manuscript will be sent to the original reviewers or others for reassessment. If there are any comments on the revised manuscript, they will be forwarded to the corresponding author, who must resubmit the revised manuscript by addressing all comments within seven days. The final decisions rest with the Editor-in-Chief or an appropriate editorial board member, based on the provided reviews. Assuming smooth progression from submission to revision, a timeframe of 6-8 weeks is typically required to reach a conclusion regarding acceptance or rejection.
Nobel Journal of Health Sciences (NJHS) requires all authors and peer reviewers to declare any conflict of interest associated with the submission or review of an article. Authors are requested to follow ethical standards as prescribed by COPE. We adopt the Uniform Requirements for Manuscripts Submitted to Biomedical Journals 2001, as adopted by the International Committee of Medical Journal Editors (ICMJE)
Authors must disclose all financial and personal relationships that could potentially bias their work. Financial relationships such as employment, consultancies, stock ownership, honoraria, paid expert testimony represents the most identifiable conflicts of interest and are the most likely to compromise the credibility of the journal. To avoid ambiguity, authors must explicitly indicate in the letter accompanying their submitted manuscript whether any potential conflicts of interest exist.
Manuscript from human participants must include a statement in the Methods section that participants gave their informed consent. It is journal policy that participant anonymity must be preserved in all cases. For experimental, clinical, and drug research, an Ethics Committee report consistent with international agreements on human rights (Helsinki Declaration) and an informed consent of patients are required.
Authors must disclose all sources of funding for their research. This includes funding from government agencies, private industry, and non-profit organizations. Authors should also disclose any financial relationships with organizations that could be perceived as influencing their work.
Authors must conduct a thorough risk assessment for their research, particularly for studies involving human participants or sensitive data. This assessment should identify potential risks to participants and outline strategies for mitigating these risks. Authors are responsible for ensuring that their research complies with all relevant ethical guidelines and regulations.
The publication of an article in a peer-reviewed journal is a crucial element in promoting a comprehensible and trusted network of information that ultimately enhances the quality of knowledge. Hence, all submitted manuscripts undergo expert peer review. We employ a double-blind peer-review system, with two to three referees (members of the Editorial Committee and/or external consultants) independently evaluating each manuscript. The referees will provide recommendation regarding acceptance, revision or rejection of the manuscript. In certain cases, specialist peer reviewers (such as statisticians) will be consulted to review specific aspects, such as study design, conduct of the study, data presentation, statistical analysis, or conclusions. If the referees suggest revision for that manuscript, authors will be requested to revise the manuscript along the lines indicated by the referees. The resubmitted manuscripts will also undergo further peer review. Once the revisions are completed and approved by the Managing Editor, the corresponding author will be notified that the article has been accepted for publication. Rejected manuscripts will be returned to the authors but their metadata will remain in the system. The average time from manuscript acceptance to publication is three months.
Authors must ensure that they have written (currently we accept manuscript written in English) original works and declared that the submitted manuscript has not been published elsewhere or has not submitted to any other journal for considering publication. Any work or words from other authors, contributors, or sources should be appropriately credited and referenced. Those submitting their works to the journal as original articles confirm that the submitted manuscript represents their contributions and have not been copied or plagiarized, in whole or in part, from other works without clear citation. All authors should disclose any financial or other conflict of interest that might influence the results or interpretation of their manuscript. When an author discovers a significant error or inaccuracy in their own published work, it is the author’s obligation to promptly notify the journal editor and cooperate in correcting the manuscript. Author(s) must agree to the license agreement before submitting their articles. All articles must be submitted using the online submission procedure.
Editors are responsible for conducting a fair double-blind peer review of submitted manuscript intended for publication. They will actively work to prevent any potential conflicts of interest between the author and the editorial and review personnel. Additionally, editors must ensure that all information related to submitted manuscripts remains confidential until publication. The editor-in-Chief will coordinate the activities of editorial team.
We request all the reviewers to evaluate the submitted manuscripts based on their contents which cover following points.
It is the responsibility of reviewer to maintain the confidentiality related to submitted manuscripts. In case of rejection, the reviewer must show the ground of rejection. If a reviewer feels unable or unqualified to review the manuscript or knows that a prompt review will be impossible, they should notify the Editor-in-Chief.
We commit to the highest standards of publication ethics and takes all measures against any publication malpractices. All parties involved in publishing - the authors, the journal editors, the peer reviewers and the publisher - agree with standards of ethical behavior.
We are committed to ensuring the highest standards of integrity, transparency, and objectivity in the scientific research we publish. So, we request comprehensive disclosure from all authors, reviewers, and editors regarding any potential conflicts of interest that could impact their contributions. Additionally, to mitigate conflicts of interest, we undergo regular updates to ensure our practices remain effective and relevance, addressing new challenges and aligning with the latest tools in scientific publication.
A conflict of interest arises when the personal, financial, or professional interests of individuals involved in the publication process could potentially or perceptibility influence an individual’s judgement and objectivity. It may be real or perceived and may involve authors, editors, reviewers, or any other parties contributing to the publication process.
The authors must disclose any potential conflicts of interest that could influence the research, its interpretation, or the presentation of their findings. This includes financial interests, affiliations, or relationships with organizations that may have a direct or indirect interest in the submitted content.
We request all authors to provide transparent information about funding sources for their research. Full disclosure of financial support, grants, or any other financial relationships that may have influenced the research is essential. This transparency allows readers and reviewers to assess the potential impact of funding sources on the study.
In cases of conflicts of interest, it is the responsibility of authors for mitigation and manage these conflicts which include clear disclosure statements within the manuscript, acknowledgment of potential biases, or other measures to ensure transparency.
Editors at the Nobel Journal of Health Sciences (NJHS) are responsible for evaluating submitted manuscripts objectively without bias. They should recuse themselves from handling a manuscript in case of any relation to personal, financial, or professional relationship with the authors that could compromise their impartiality.
The scientific merit and alignment of the journal’s aims and scope are prime factors in making fair decisions. If conflicts arise during the review process, editors should take appropriate actions, which may include seeking additional reviews or consulting with other members of the editorial board.
In cases where editors have conflicts of interest, it is essential to maintain transparency in the decision-making process. Editors must clearly communicate any potential conflicts and actively work to minimize their effects, ensuring that the publication process remains fair and unbiased.
Reviewers are essential for upholding the integrity of the peer-review process. They should evaluate manuscripts objectively, without personal, financial, or professional biases that could affect their assessment.
It is the responsibility of reviewers to disclose any conflicts of interest to the editorial team. If a potential conflict arises after accepting a review assignment, reviewers should inform the editor immediately, so that appropriate actions, such as reassignment of the review, can be taken.
Reviewers are expected to maintain confidentiality and integrity throughout the review process. Any information obtained during this review process must be handled responsibly, and reviewers should refrain using unpublished information for personal gain or biased decision-making.
Publisher of the Nobel Journal of Health Sciences (NJHS) is committed to maintaining transparency in its operations. We understand that any potential conflicts of interest involving the publisher, editorial team, or other stakeholders can impact the publication process.
Editorial independence is essential, and decisions are made without any external influences. The acceptance or rejection of a manuscript is based on the quality of the research paper and its alignment with the journal’s aim and scope.
The conflict resolution process involves a thorough investigation, consultation with relevant parties, and the implementation of appropriate measures to ensure a fair and impartial resolution.
The investigation process will be initiated promptly upon identification of a potential conflict. This may involve gathering information from relevant parties, including authors, reviewers, and editorial staff.
Consultation with relevant stakeholders will be conducted to gain a comprehensive understanding of the situation. This may include discussions with the editorial team, legal advisors, and other experts as needed.
Based on the findings of the investigation and consultation, appropriate measures will be implemented to address the conflict. This may include re-evaluating the manuscript, changing reviewers, or other actions as deemed necessary.
Through continuous training and periodic reviews, we aim to maintain the objectivity of journal. We offer various training programs for authors, editors, reviewers, and others involved in the publication process. These programs are designed to reinforce ethical standards and promote a culture of transparency and integrity. Through periodic reviews, we address emerging challenges and align with evolving best practices in the field of scientific publishing.
We are committed to maintain strict integrity standards in scholarly publishing and regard plagiarism as serious violation of academic and ethical norms. We have a zero tolerance policy for plagiarism. To ensure the originality of the work we publish, we have implemented a comprehensive plagiarism policy. Points covered in this policy include:
Authors are encouraged to:
Authors submitting previously deposited manuscripts or theses must:
We are committed to keeping the integrity of scientific research and scrutinize any concerns that are brought to our attention by authors or readers. To address these issues thoroughly and transparently, we follow a comprehensive Correction and Retraction Policy. This policy details the procedures and outcomes related to potential errors, providing a systematic approach to uphold the credibility and reliability of the research we publish.
Any articles may be retracted from Nobel Journal of Health Sciences (NJHS) if potentially serious issue are raised. We follows COPE guidelines for retracting a published article. An article will be retracted if:
We are dedicated to nurturing open access to scientific research and promoting the wider dissemination of knowledge. Our self-archiving policy encourages the sharing of their research findings at various stages of the publication process, from pre-submission to the final published article. This approach ensures that valuable scientific work is not confined by paywalls and is readily accessible to the global research community.
Authors are encouraged to share their pre-submission manuscripts on preprint servers or repositories from following lists before submitting to the Nobel Journal of Health Sciences (NJHS). This early dissemination promotes engagement with fellow researchers and subject experts, the helps to enhance the visibility and impact of the work. When submitting the manuscript, authors should provide details about the pre-submitted manuscript, such as the repository and the corresponding DOI, in their cover letter.
Authors may archive their manuscripts after submission but prior to the commencement of the peer review process. To maintain transparency, authors are required to email the journal's editorial office with details regarding the repository and the corresponding DOI where the manuscript is archived.
During the peer review process, authors are allowed to archive their manuscripts. To ensure accurate documentation and transparency, they should send an email to editorial office, including details about the repository and the associated DOI.
Once a manuscript is accepted for publication, authors are permitted to archive the accepted version. To do so, authors must email the editorial office with details about the repository and corresponding DOI.
After formal publication in NJHS, authors can archive their published articles. It is important to update the DOI linked to the pre-print so that it aligns with the DOI provided by the journal for the published version. Authors are encouraged to share their published articles through various channels, including social media platforms, research platforms, institutional repositories, personal websites, and blogs, to promote broader dissemination and access to their research findings.
Digital archiving and preservation policies aim to ensure the longevity, accessibility, and integrity of scholarly content published in our journal. These policies reflect our commitment to the preserving scientific knowledge for both current and future generations.
Nobel Journal of Health Sciences (NJHS) uses a server redundancy system to reduce the risk of data loss from hardware failures or other unexpected events. Our content is hosted on secure and reliable servers equipped with redundant storage solutions, which helps minimize the chances of service disruptions.
Regular, automated backups of all published content are conducted to safeguard against data loss.
We follow open access policy such the all the articles once published can be freely downloaded from any place.
We follow international accessibility standards to make our digital content accessible to individuals with disabilities. Our commitment is to deliver a user-friendly experience for all readers, promoting inclusivity and diversity in the sharing of scientific knowledge.
To enhance discoverability and interoperability, we adhere to establish metadata standards such as Dublin Core. This practice ensures that our content is easily indexed by search engines, repositories, and other scholarly databases, thereby enhancing the global visibility of published research.
Nobel Journal of Health Sciences (NJHS) assigns Digital Object Identifiers (DOIs) to each published articles. DOIs serve as persistent and unique identifier, enabling accurate citation, linking, and long-term retrieval of scholarly content.
All the articles in this journals are licensed under the Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, as long as the original work is properly cited.
Authors publishing with NHJS retain their intellectual property rights. Our licensing agreements are crafted to balance the need for widespread dissemination with the protection of these rights.
To improve the discoverability and accessibility of content, Nobel Journal of Health Sciences (NJHS) actively engages in cross-linking initiatives with reputable scholarly databases, repositories, and indexing services. This interconnectivity facilitates the wider dissemination of research findings.
We encourage authors to use Open Researcher and Contributor ID (ORCID) identifiers. This practice facilitates seamless integration with institutional repositories and ensure accurate attribution of scholarly contributions.
Nobel Journal of Health Sciences (NJHS) regularly conducts audits of its digital preservation practices to evaluate the effectiveness of its archiving strategies. These audits assess data integrity, file formats, and compliance with preservation best practices.
Nobel Journal of Health Sciences (NJHS) is committed to continually improving its digital archiving and preservation policies. We draw feedback from the scholarly community, advancements in digital preservation technologies, and emerging best practices to enhance the reliability and sustainability of our digital repository.
The Nobel Journal of Health Sciences (NJHS) is dedicated to maintaining the highest ethical standards in scientific research and publication. A key aspect of this commitment is the firm adherence to informed consent policies, which are essential for protecting and ethically treating human subjects involved in research. This overview outlines NJMS's informed consent policies, accentuating the significance of transparency, ethical conduct, and the welfare of research participants.
NJHS recognizes the critical importance of protecting the rights and well-being of individuals involved in research. Informed consent is a key ethical principle that emphasizes respect for autonomy and ensures that participants are fully up-to-date about the nature, purpose, and potential risks associated with research.
NJHS strictly follows internationally recognized ethical guidelines, including the Declaration of Helsinki and the International Conference on Harmonization (ICH) guidelines for Good Clinical Practice. These guidelines provide a framework for the ethical conduct of research involving human subjects, highlighting the importance of informed consent.
This process starts by providing potential research participants with clear and comprehensive information which includes details about the research objectives, procedures, potential risks and benefits, confidentiality measures, and the right to withdraw from the study at any time without facing any consequences.
We are committed to ensuring that informed consent documents are written in local language. For those with limited literacy or language barriers, we take extra steps to enhance comprehension, including providing translations and using visual aids.
Individuals participating in research have the right to choose freely whether or not to take part in the study, without any pressure. They can withdraw from the study at any time without facing penalty. This voluntary nature of participation is reiterated throughout the research process.
Participants must provide written consent using a consent form that has been reviewed and approved by the Institutional Review Board (IRB) or the ethics committee overseeing the study. The consent form includes all necessary information and is signed by both the participant and the researcher. In the case of minors, individuals who are unable to provide consent due to their health condition, or individual with cognitive impairments, informed consent must be obtained from their legal guardians. For longitudinal study, participants are regularly updated on research progress with clause of any time deny to participate.
All research involving human subjects submitted to NJHS undergoes a thorough ethical review by an Institutional Review Board or ethics committee. Obtaining IRB approval is mandatory for publication, ensuring the study adhere to ethical standards and that the informed consent process aligns with established guidelines.
We prioritize the protection of participant privacy and confidentiality. Informed consent documents clearly details the measures taken to safeguard participant data, ensuring that individual identities remain confidential. For this researchers must implement robust data security measures to protect participant information. This includes secure data storage, restricted access to identifiable information, and compliance with data protection regulations.
NJHS values participant feedback and encourages open communication throughout and after the research process. Participants will receive updates on the study outcomes and are given options to address any concerns or questions they may have.
The Nobel Journal of Health Sciences (NJHS) is committed to creating scholarly environment that promote scientific exploration and collaboration. To that end, we have developed a comprehensive advertising policy that clearly outline our stance on advertising within our platform. This policy emphasizes our commitment to maintaining the integrity, objectivity, and independence of our scientific work.
We have chosen to abstain from advertising in order to build and maintain trust with our readership. Our primary goal is to uphold the scientific integrity of the content in our journal. By avoiding advertising, we eliminate potential conflicts of interest that could arise from financial relationships with external entities. This allows us to ensure that the information we share is based entirely on transparent, evidence-based scientific merit and the pursuit of knowledge. Moreover, the absence of advertising protects the editorial independence of our content. Editorial decisions such as the selection and publication of manuscripts, are made solely based on scientific merit, relevance, and contributions to the field of health science.
The Nobel Journal of Health Sciences (NJHS) operates under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International License (CC BY-NC 4.0).
As an open access journal, NJHS allows anyone to freely download all published articles. We also have an author-centric copyright policy that enables authors to retain the copyright to their article, and granting third parties the rights to use, reproduce, and disseminate their articles. This facilitate broader distribution of authors’ work, provided that provided that proper attribution is given.
